Bookmark
Forward
Explore Literature Results
Explore Clinical Trials Results
QuickView for MDM2 (gene)
Most Relevant Literature
- Dysfunction of the MDM2/p53 axis is linked to premature aging.
- Splice variants of MDM2 in oncogenesis.
- Non-linear feedback control of the p53 protein-mdm2 inhibitor system using the derivative-free non-l…
- MDM2 prevents spontaneous tubular epithelial cell death and acute kidney injury.
- MDM2 beyond cancer: podoptosis, development, inflammation, and tissue regeneration.
Most Relevant Clinical Trials
- MDM2 Inhibitor AMG-232 (KRT-232) and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
- Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer
- Ascending Dose and Exploratory Expansion Study of DS-3032b, an Oral MDM2 Inhibitor, in Subjects With…
- This Study Evaluates KRT-232, a Novel Oral Small Molecule Inhibitor of MDM2, for the Treatment of Pa…
- A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanc…
